In conclusion, our results show that cytokines and inhibitors regulate MMP-2 and MMP-9 expression in adult sarcoma cell lines, suggesting the clinical value of targeting these proteases for management of sarcomas and their pathogenesis. This evidence concerns the gene MMP9 and sarcoma.